Pelvic Organ Prolapse Repair with and without Concomitant Burch Colposuspension in Incontinent Women: A Randomised Controlled Trial with at Least 5-Year Followup

Table 1

Demographic and clinical variables of groups A and B. Patient data.

Colposuspension	Yes (24 patients)	No (23 patients)	P
Age (years; mean/range)	60.0 ± 10.6 (35.1–79.0)	62.6 ± 12.8 (26.9–76.4)	NS
Menopause (n/%)	18 (75.0)	18(78.3)	NS
Previous urogynecological surgery	5 (20.8)	9 (39.1)	NS
Hysterectomy	5 (20.8)	8 (34.8)	NS
Prolapse repair	4 (16.7)	5 (21.7)	NS
SUI surgery	0 (0.0)	2 (8.7)	NS
BMI (kg/m^2, median/range)	25.6 (20.8–35.2)	27.0 (16.0–31.9)	NS
Parity (median/range)	2 (0–3)	2 (1–3)	NS
ureterocele stage I	1 (4.2)	4 (17.4)	NS
ureterocele stage II	6 (25.0)	8 (34.8)
ureterocele stage III	17 (70.8)	11 (47.8)
Heart diseases (n/%)	2 (8.3)	1 (4.3)	NS
Hypertension (n/%)	6 (25.0)	8 (34.8)	NS
Hypercholesterolemy (n/%)	4 (16.7)	6 (26.1)	NS
Lower limb varices (n/%)	6 (25.0)	3 (13.0)	NS
COPD (n/%)	1 (4.2)	2 (8.7)	NS
Auto-immune disease (n/%)	2 (8.3)	3 (13.0)	NS
Anxiety (n/%)	5 (20.8)	6 (26.1)	NS
Diabetes mellitus type 2 (n/%)	2 (8.3)	3 (13.0)	NS
Recurrent urinary tract infections	2 (8.3)	3 (13.0)	NS
Hypothyroidism (n/%)	1 (4.2)	2 (8.7)	NS
Hydronephrosis (n/%)	1 (4.2)	0 (0.0)	NS